ES356551A1 - Un procedimiento para la preparacion de composiciones far- maceuticas de accion prolongada en dosis administrables en forma oral. - Google Patents

Un procedimiento para la preparacion de composiciones far- maceuticas de accion prolongada en dosis administrables en forma oral.

Info

Publication number
ES356551A1
ES356551A1 ES356551A ES356551A ES356551A1 ES 356551 A1 ES356551 A1 ES 356551A1 ES 356551 A ES356551 A ES 356551A ES 356551 A ES356551 A ES 356551A ES 356551 A1 ES356551 A1 ES 356551A1
Authority
ES
Spain
Prior art keywords
translation
preparation
machine
pharmaceutical compositions
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES356551A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COTTY
Original Assignee
COTTY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COTTY filed Critical COTTY
Publication of ES356551A1 publication Critical patent/ES356551A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES356551A 1967-08-01 1968-07-26 Un procedimiento para la preparacion de composiciones far- maceuticas de accion prolongada en dosis administrables en forma oral. Expired ES356551A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65749667A 1967-08-01 1967-08-01

Publications (1)

Publication Number Publication Date
ES356551A1 true ES356551A1 (es) 1970-02-01

Family

ID=24637422

Family Applications (1)

Application Number Title Priority Date Filing Date
ES356551A Expired ES356551A1 (es) 1967-08-01 1968-07-26 Un procedimiento para la preparacion de composiciones far- maceuticas de accion prolongada en dosis administrables en forma oral.

Country Status (4)

Country Link
BE (1) BE718710A (fr)
ES (1) ES356551A1 (fr)
FR (1) FR7749M (fr)
NL (1) NL6810371A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3832277A1 (de) * 1988-09-22 1990-03-29 Guenter Stephan Brausetablette

Also Published As

Publication number Publication date
BE718710A (fr) 1969-01-27
FR7749M (fr) 1970-03-16
NL6810371A (fr) 1969-02-04

Similar Documents

Publication Publication Date Title
BE575313A (fr) Composition médicamenteuse pour administration buccale comprenant une masse poreuse et un médicament solide
SE7416039L (fr)
PH13841A (en) Pharmaceutical preparation adapted for oral administration
JPS5241214A (en) Method of making preparations for oral administration
ZA764868B (en) Novel pharmaceutical preparation adapted for oral administration
IL51096A0 (en) Novel pharmaceutical dosage form
IL30001A0 (en) Phenoxyalkanolamines,processes for their preparation and pharmaceutical compositions containing them
DK123141B (da) Fremgangsmåde til stabilisering af et til oral indgift egnet farmaceutisk præparat, indeholdende en basisk dihydrodibenzazepin.
JPS52108028A (en) Remedies for dysacousis
ES356551A1 (es) Un procedimiento para la preparacion de composiciones far- maceuticas de accion prolongada en dosis administrables en forma oral.
IL30594A0 (en) New pharmaceutical steroidal compositions,especially useful for treatment of climacteric disorders
ES449797A1 (es) Un procedimiento para preparar derivados de 1,3,8-tiazaspiro4,5 deon-4-ona.
ES294897A1 (es) Mejoras introducidas en la preparación de composiciones farmacéuticas en forma de dosis unitarias
ES362231A1 (es) Procedimiento de preparacion de un compuesto de accion hi- poglicemica.
GB1049996A (en) New medicine with anti-inflammatory and anti-rheumatic activity
ES283585A1 (es) Un procedimiento para la preparación de una composición terapéutica
OA06135A (fr) Composition pharmaceutique administrable par voie orale.
GB1367608A (en) Oral pharmaceutical dosage form
IL30959A (en) New cyclopeptides,process for their preparation and pharmaceutical compositions containing them
ES361494A1 (es) Procedimiento para la preparacion de medicamentos con libe-racion prolongada de la sustancia activa.
ES287586A1 (es) Un procedimiento para la preparación de una composición terapéutica
ES306376A1 (es) Procedimiento para la preparacion de una composicion farmaceutica.
CA957280A (en) Progestational composition in oral dosage form
NL158504B (nl) Werkwijze ter bereiding van esters van 17 beta-hydroxy-(delta)4-androsteen-3-on, werkwijze ter bereiding van een gedoseerd farmaceutisch preparaat, en voor geneeskundige toediening geschikte vormstukken.
GB976096A (en) Pharmaceutical compositions